FDA to hold meeting of risk communication advisory board
This article was originally published in Scrip
Executive Summary
The US FDA has scheduled a meeting of its Risk Communication Advisory Committee on 8-9 November, and the topics include an update on the agency's strategic plan for risk communication to the public, released last year, and its transparency initiative, which is part of the Obama administration's plan for more openness in government.